Zydus’ Nesher Pharma gets US FDA nods for influenza drug
The drug will be produced at Nesher Pharmaceuticals manufacturing facility located at St Louis, US
Author
Lupin appoints Jim Loerop as Chief Corporate Development Officer
He will be responsible for the company’s global M&A and business development functions
Advanced GMP Workshops 2017 to be held across four cities in India
The workshop is for supervisory and middle level managers in manufacturing, quality and regulatory functions in industry and CDSCO…
US FDA approves Bayer’s drug for follicular lymphoma
The drug, Aliqopa, known also as copanlisib, is a kinase inhibitor that blocks certain enzymes that promote cell growth
Pfizer, Astellas prostate cancer drug promising in late-stage trial
Pfizer and Astellas jointly sell Xtandi in the US, while Astellas owns the rights to develop and sell Xtandi outside the US
CCI to study pricing issue in pharma, healthcare sector
The proposal, mooted by the regulator, comes amid concerns over anti-competitive practices in the pharmaceutical and healthcare…
Lupin Pharmaceuticals recalls 12,888 bottles of ulcer drug in US
The reason for the recall is current CGMP deviations
IDMA-NSF programme to inaugurate on Sept 25
The first module for the first batch will start on Sept 26
Lupin gets US FDA nod to market generic anti-bacterial drug
The product is a generic version of GD Searle's Flagyl tablets